⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15166545 | 0.59 | — | — | |
| SCHEMBL22636 | 0.59 | — | — | |
| SCHEMBL5080727 | 0.59 | — | — | |
| SCHEMBL17836978 | 0.56 | — | — | |
| SCHEMBL91335 | 0.56 | — | — | |
| SCHEMBL28031030 | 0.56 | — | — | |
| SCHEMBL7979359 | 0.56 | — | — | |
| SCHEMBL9817873 | 0.56 | — | — | |
| SCHEMBL16592963 | 0.56 | — | — | |
| SCHEMBL14878022 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060263447-A1 | Treating pulmonary disorders with gaseous agent causing repletion of GSNO | DUKE UNIVERSITY | 2006-11-23 | — | — | US | claimed |
| US-7045152-B2 | Treating pulmonary disorders with gaseous agent causing repletion of GSNO | DUKE UNIVERSITY (US) | 2006-05-16 | — | — | US | claimed |
| US-20170358645-A1 | HIGH MOBILITY NANOWIRE FIN CHANNEL ON SILICON SUBSTRATE FORMED USING SACRIFICIAL SUB-FIN | TAHOE RESEARCH, LTD. (IE) | 2017-12-14 | — | — | US | disclosed |
| US-20170348729-A1 | METHOD FOR FORMING FINE PATTERNS | TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2017-12-07 | — | — | US | disclosed |
| US-9810052-B2 | Multilateral wells placement via transshipment approach | SAUDI ARABIAN OIL COMPANY (SA) | 2017-11-07 | — | — | US | disclosed |
| US-20170311782-A1 | IMAGE PROCESSING APPARATUS, METHOD, AND COMPUTER PROGRAM PRODUCT | OLYMPUS CORPORATION (JP) | 2017-11-02 | — | — | US | disclosed |
| EP-2408476-B1 | HUMAN IMMUNODEFICIENCY VIRUS (HIV) -NEUTRALIZING ANTIBODIES | THERACLONE SCIENCES INC (US) | 2017-10-18 | — | — | EP | disclosed |
| US-9793555-B2 | Membrane electrode assembly with gas diffusion layers having a rib porosity and method of manufacturing the same, as well as fuel cell | PANASONIC CORPORATION (JP) | 2017-10-17 | — | — | US | disclosed |
| US-20170285196-A1 | DETERMINING DISPLACEMENT BETWEEN SEISMIC IMAGES USING OPTICAL FLOW | BP CORPORATION NORTH AMERICA INC. (US) | 2017-10-05 | — | — | US | disclosed |
| US-20170275671-A1 | METHODS AND SOLUTIONS FOR INHIBITING UNDESIRED CLEAVING OF LABELS | IsoPlexis Corporation | 2017-09-28 | — | — | US | disclosed |
| US-20170257905-A1 | RELEASING CONNECTIONS WITH LOCAL GW WHEN UE MOVES OUT OF RESIDENTIAL/ENTERPRISE NETWORK COVERAGE | MALIKIE INNOVATIONS LIMITED (IE) | 2017-09-07 | — | — | US | disclosed |
| US-8946507-B2 | Method of selectively producing male or female sterile plants | SYNGENTA LIMITED (GB) | 2015-02-03 | — | — | US | disclosed |
| US-8933145-B2 | High temperature melting | THE GENERAL HOSPITAL CORPORATION (US) | 2015-01-13 | — | — | US | disclosed |
| US-20130283783-A1 | CONTROL APPARATUS FOR INTERNAL COMBUSTION ENGINE | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2013-10-31 | — | — | US | disclosed |
| EP-2602320-A1 | DNA encoding novel enzyme having D-serine synthase activity, method of producing the enzyme and method of producing D-serine by using the same | Mitsui Chemicals, Inc. (JP) | 2013-06-12 | — | — | EP | disclosed |
| US-8421076-B2 | Insulating substrate for semiconductor apparatus, semiconductor apparatus, and method for manufacturing semiconductor apparatus | SHARP KABUSHIKI KAISHA (JP) | 2013-04-16 | — | — | US | disclosed |
| EP-1365778-B1 | TREATING PULMONARY DISORDERS WITH GASEOUS AGENT CAUSING REPLETION OF GSNO | UNIV DUKE (US) | 2011-01-05 | — | — | EP | disclosed |
| US-20060263447-A1 | Treating pulmonary disorders with gaseous agent causing repletion of GSNO | DUKE UNIVERSITY | 2006-11-23 | — | — | US | disclosed |
| US-7045152-B2 | Treating pulmonary disorders with gaseous agent causing repletion of GSNO | DUKE UNIVERSITY (US) | 2006-05-16 | — | — | US | disclosed |
| US-20010012834-A1 | Treating pulmonary disorders with gaseous agent causing repletion of GSNO | DUKE UNIVERSITY (US) | 2001-08-09 | — | — | US | disclosed |